Smith & Nephew PLC (SNN)
24.36
+0.52
(+2.18%)
USD |
NYSE |
Apr 22, 16:00
24.38
+0.02
(+0.08%)
Pre-Market: 20:00
Smith & Nephew Price to Book Value: 2.041 for April 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 2.041 |
| April 19, 2024 | 1.998 |
| April 18, 2024 | 2.012 |
| April 17, 2024 | 2.004 |
| April 16, 2024 | 1.994 |
| April 15, 2024 | 1.994 |
| April 12, 2024 | 1.992 |
| April 11, 2024 | 2.055 |
| April 10, 2024 | 2.040 |
| April 09, 2024 | 2.066 |
| April 08, 2024 | 2.040 |
| April 05, 2024 | 2.050 |
| April 04, 2024 | 2.040 |
| April 03, 2024 | 2.062 |
| April 02, 2024 | 2.034 |
| April 01, 2024 | 2.056 |
| March 28, 2024 | 2.125 |
| March 27, 2024 | 2.207 |
| March 26, 2024 | 2.185 |
| March 25, 2024 | 2.165 |
| March 22, 2024 | 2.195 |
| March 21, 2024 | 2.185 |
| March 20, 2024 | 2.214 |
| March 19, 2024 | 2.257 |
| March 18, 2024 | 2.235 |
| Date | Value |
|---|---|
| March 15, 2024 | 2.263 |
| March 14, 2024 | 2.303 |
| March 13, 2024 | 2.331 |
| March 12, 2024 | 2.346 |
| March 11, 2024 | 2.341 |
| March 08, 2024 | 2.317 |
| March 07, 2024 | 2.308 |
| March 06, 2024 | 2.298 |
| March 05, 2024 | 2.231 |
| March 04, 2024 | 2.221 |
| March 01, 2024 | 2.214 |
| February 29, 2024 | 2.221 |
| February 28, 2024 | 2.215 |
| February 27, 2024 | 2.343 |
| February 26, 2024 | 2.391 |
| February 23, 2024 | 2.42 |
| February 22, 2024 | 2.418 |
| February 21, 2024 | 2.395 |
| February 20, 2024 | 2.387 |
| February 16, 2024 | 2.351 |
| February 15, 2024 | 2.348 |
| February 14, 2024 | 2.324 |
| February 13, 2024 | 2.307 |
| February 12, 2024 | 2.334 |
| February 09, 2024 | 2.333 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.771
Minimum
Sep 27 2022
4.396
Maximum
Feb 20 2020
2.974
Average
2.883
Median
Nov 11 2021
Price to Book Value Benchmarks
| AstraZeneca PLC | 5.554 |
| Adaptimmune Therapeutics PLC | 6.309 |
| Biodexa Pharmaceuticals Plc | 0.5629 |
| Verona Pharma PLC | 5.096 |
| NuCana PLC | 0.4449 |
Price to Book Value Related Metrics
| PE Ratio | 40.47 |
| PS Ratio | 1.918 |
| Price | 24.36 |
| Earnings Yield | 2.47% |
| Market Cap | 10.65B |
| Operating PE Ratio | 16.13 |
| Normalized PE Ratio | 40.47 |